From Mount Sinai: Muscle invasive bladder cancer: from diagnosis to survivorship

http://www.ncbi.nlm.nih.gov/pubmed/22924038

Adv Urol. 2012;2012:142135. Epub 2012 Aug 10.

Muscle invasive bladder cancer: from diagnosis to survivorship.

Mohamed NE, Diefenbach MA, Goltz HH, Lee CT, Latini D, Kowalkowski M, Philips C, Hassan W, Hall SJ.

Source

Department of Urology and Oncological Science, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

Abstract

Bladder cancer is the fifth most commonly diagnosed cancer and the most expensive adult cancer in average healthcare costs incurred per patient in the USA. However, little is known about factors influencing patients' treatment decisions, quality of life, and responses to treatment impairments. The main focus of this paper is to better understand the impact of muscle invasive bladder cancer on patient quality of life and its added implications for primary caregivers and healthcare providers. In this paper, we discuss treatment options, side effects, and challenges that patients and family caregivers face in different phases along the disease trajectory and further identify crucial areas of needed research.